Insider trades

AH Bio Fund II, 10% Owner of Nautilus Biotechnology NAUT, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $11.8M. The latest trade was on 06/02.

AH Bio Fund II

10% Owner
First filing
23/01/04
Trades
13 trades
Buys / sales
0 / 2
12-month net buying
−$11.8M
Last trade
06/02

Trading activity

Transactions

Trade type
NAUT
Open-market sale06/0206/045,000,000 sh2 trades$2.35avg.$11,750,000−83.7%